Brief: Q32 Bio Appoints Adrien Sipos As Interim Chief Medical Officer
25/06/2025 11:59
June 25 (Reuters) - Q32 Bio Inc QTTB.O: Q32 BIO APPOINTS ADRIEN SIPOS, M.D., PH.D., AS INTERIM CHIEF MEDICAL OFFICER Source text: ID:nPn6BzH6Na Further company coverage: QTTB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Q32 Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Q32 Bio Reports Second Quarter 2026 Financial Results And Provides Corporate Update
Q32 Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Q32 Bio Inc expected to post a loss of 54 cents a share - Earnings Preview